URAC vs ACHC Pharmacy Accreditation — Side-by-Side Comparison
Last updated: October 2026
URAC and ACHC both accredit pharmacies in the United States. Understanding which program your organization needs — or whether you need both — requires comparing payer preference, standards focus, deeming authority, specialty designations, survey process, and renewal requirements. This comparison is prepared by IHS, led by Thomas G. Goddard, JD, PhD, former Chief Operating Officer and General Counsel of URAC.
At a Glance: URAC vs ACHC Pharmacy Accreditation
URAC — Utilization Review Accreditation Commission
URAC's pharmacy programs emphasize clinical patient management, operational quality metrics, and five core performance measures. URAC accreditation does not carry Medicare/Medicaid deeming authority for pharmacy.
ACHC — Accreditation Commission for Health Care
ACHC is a CMS-approved deeming authority for certain pharmacy programs, meaning ACHC accreditation can satisfy Medicare/Medicaid certification requirements for applicable services. ACHC also offers specialty disease state designations — oncology, HIV, and rare and orphan diseases — that URAC does not. ACHC's focus is on pharmacy operations, patient care outcomes, and organizational management including fiscal and human resources.
The Third Option: CPPA
The Center for Pharmacy Practice Accreditation (CPPA) offers a third accreditation option.
Payer Preference and Market Access
Commercial Payer Network Access
Which accreditor a commercial payer accepts is set by its own contract language, so check the accreditation terms in your commercial contracts.
Limited Distribution Network (LDN) Access
For specialty pharmacies seeking access to pharmaceutical manufacturer limited distribution networks, both URAC and ACHC are recognized credentials. Manufacturers that grant exclusive dispensing contracts for high-cost specialty and orphan drugs may require accreditation, and each sets which bodies it accepts. Review the specific LDN requirements of the manufacturers whose products are most strategically important to your organization.
Government Program Access
ACHC is a CMS-approved deeming authority, meaning ACHC accreditation can satisfy Medicare/Medicaid certification requirements for applicable pharmacy services. Organizations whose market includes Medicare Part D or Medicaid pharmacy services can include ACHC in their evaluation.
Employer Group and TPA Requirements
Employer groups and third-party administrators contracting with PBMs may specify an accreditation in their procurement requirements. Organizations serving employer group clients should verify whether their contract requirements specify URAC, ACHC, or either program.
Standards Focus and Accreditation Philosophy
URAC's Approach: Clinical Performance and Operational Metrics
URAC's pharmacy standards emphasize clinical patient management quality and measurable operational performance. URAC requires organizations to collect and report data on five core performance measures — drug-drug interaction management, call center performance, dispensing accuracy, distribution accuracy, and prescription turnaround time — and to demonstrate ongoing performance monitoring rather than just documenting intent.
URAC's standards modules include Customer Service, Communications and Disclosure (CSCD); Drug Management; Pharmacy Operations (Pharm-Op); Performance Monitoring and Improvement; Consumer Protection and Empowerment; and Risk Management. The CSCD module alone contains 13 standards focused on call center and patient assistance operations.
URAC accreditation requires ongoing performance reporting. Organizations must have functioning data collection infrastructure before the survey — not just policies describing what data will be collected.
ACHC's Approach: Organizational Operations and Outcomes
ACHC's pharmacy standards evaluate organizational structure, patient care outcomes, fiscal management, and human resources management alongside clinical operations. ACHC's approach looks at how the pharmacy functions as an organization as well as how it processes prescriptions.
ACHC also evaluates patient care outcome data, but the specific performance measure requirements differ from URAC's five-measure framework. ACHC's standards are updated periodically — organizations should review current ACHC standards documentation for the specific requirements applicable to their program version.
Specialty Pharmacy Standards: URAC v6.0 vs ACHC
For organizations operating specialty pharmacies (dispensing specialty medications with patient management services), URAC Specialty Pharmacy v6.0 (announced October 2025) and ACHC's specialty pharmacy program are the relevant credentials. URAC Specialty Pharmacy v6.0 covers nine operational modules across 40+ standards. ACHC offers specialty pharmacy accreditation with additional disease-state designations in oncology, HIV, and rare and orphan diseases — designations that URAC does not offer.
Whether a commercial payer prefers URAC Specialty Pharmacy Accreditation for specialty pharmacy network access depends on that payer's contract language.
Deeming Authority and Regulatory Status
ACHC: CMS-Approved Deeming Authority
ACHC is a CMS-approved deeming authority for certain healthcare programs. This means ACHC can conduct surveys to determine whether facilities meet Medicare and Medicaid certification requirements, and can conduct unannounced inspections. For pharmacy services that fall under CMS certification requirements, ACHC accreditation can satisfy those requirements directly.
Pharmacies and pharmacy networks with Medicare or Medicaid business can include ACHC in their evaluation.
URAC: No Deeming Authority for Pharmacy
URAC accreditation does not carry Medicare/Medicaid deeming authority for pharmacy programs. Organizations whose payer contracts call for URAC and who also want CMS deeming may need both URAC and ACHC accreditation.
Specialty Designations and Disease State Recognition
ACHC Specialty Designations
ACHC offers disease-state specialty designations alongside its core pharmacy accreditation that URAC does not provide:
- Oncology designation — recognition for pharmacies specializing in oncology drug management and patient support
- HIV designation — recognition for pharmacies specializing in HIV/AIDS medication management
- Rare and orphan disease designation — recognition for pharmacies serving rare disease patient populations
- Ambulatory infusion designation — recognition for ambulatory infusion pharmacy services
- Compounding pharmacy designation — recognition for compounding pharmacy operations
These designations are additive to core ACHC accreditation and allow specialty pharmacies to signal disease-state expertise to referring clinicians, pharmaceutical manufacturers, and payers who manage specific patient populations.
URAC Pharmacy Programs
URAC does not offer disease-state specialty designations for pharmacy. URAC's pharmacy programs — Pharmacy Services and Specialty Pharmacy — recognize operational quality and clinical management across the pharmacy's full patient population rather than distinguishing disease-state expertise.
Survey Process Comparison
URAC Survey Process
The URAC pharmacy accreditation survey has three phases: desktop review (30-45 days), validation review, and committee decision. The desktop review evaluates submitted documentation — policies, procedures, and performance data — against applicable standards. URAC issues Requests for Information (RFIs) when documentation gaps are identified; organizations must respond within defined windows. The URAC accreditation committee makes the final accreditation decision.
ACHC Survey Process
ACHC conducts an on-site survey — a direct inspection of your pharmacy operations — as part of its accreditation process. ACHC's status as a CMS deeming authority means it can conduct unannounced inspections. Organizations preparing for ACHC accreditation must ensure that their operations match their submitted documentation in real time — not just for the scheduled survey, but for any unannounced ACHC visit.
Key Process Difference: Document Review vs On-Site Survey
One process difference between URAC and ACHC pharmacy accreditation is the survey method. URAC's pharmacy accreditation starts with a desktop review of what you submit, followed by a validation review. ACHC's on-site survey evaluates how your pharmacy operates on the day of inspection.
Dual Accreditation Strategy
When to Pursue Both URAC and ACHC
Organizations consider dual URAC and ACHC accreditation when:
- Your organization serves both commercial payer markets and government programs (where ACHC provides deeming authority)
- You are seeking access to limited distribution networks where individual manufacturers require specific accreditation bodies
- Your specialty pharmacy focuses on oncology, HIV, or rare disease populations where ACHC offers disease-state designations
- Your main employer group or health plan contracts specify both URAC and ACHC as preferred credentials
Sequencing Dual Accreditation
Organizations pursuing dual accreditation should not run both survey processes simultaneously unless they have dedicated compliance resources for each. The order depends on which payer contracts or requirements come first. Where one accreditation is already required, that one goes first, and the documentation infrastructure built for it carries into the second. Policy frameworks developed for one program can be adapted for the other.
IHS coordinates dual-accreditation strategies and can structure the engagement to maximize documentation overlap between URAC and ACHC requirements.
When to Pursue Only One Program
Single-accreditation is appropriate when your market access goals are clearly served by one program. If your organization serves exclusively commercial managed care clients and has no government program exposure, URAC alone may provide all the market access you need. If your organization serves exclusively Medicare/Medicaid populations and disease-state designations are strategically important, ACHC alone may be sufficient. Review your specific payer mix and contract requirements before committing to dual accreditation resources.
IHS Perspective: How to Choose
IHS consults on both URAC and ACHC pharmacy accreditation programs. Our recommendation framework starts with three questions:
- What do your current and target payer contracts require? Review the accreditation requirements in your existing contracts and in the RFPs of the contracts you are actively pursuing. This shows which credential your contracts call for.
- Do you have or seek Medicare/Medicaid pharmacy business? If yes, ACHC's deeming authority has direct regulatory value. If no, this differentiator is less relevant to your decision.
- Does your specialty pharmacy compete on disease-state expertise? If you are positioning as an oncology, HIV, or rare disease specialist, ACHC offers disease-state designations.
Thomas G. Goddard, JD, PhD — former Chief Operating Officer and General Counsel of URAC — provides this assessment based on direct institutional knowledge of how URAC standards are developed and applied. IHS prepares pharmacies for both URAC and ACHC accreditation.
Schedule a Free Discovery Session
Talk directly with Thomas G. Goddard, JD, PhD — former Chief Operating Officer and General Counsel of URAC — about which pharmacy accreditation program fits your organization's market access goals, payer mix, and operational baseline.